PHASE-II CLINICAL-TRIALS WITH VINDESINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
MATHE, G
HULHOVEN, R
SOKAL, G
BAYSSAS, M
BELPOMME, D
BOSLY, A
CORNU, G
DELANNOY, A
DELUCA, L
DEVASSAL, F
FERRANT, A
GOUVEIA, J
HAYAT, M
JASMIN, C
MACHOVER, D
MICHAUX, JL
MISSET, JL
MUSSET, M
PICO, JL
RIBAUD, P
SCHWARTZENBERG, L
机构：
[1] HOP PAUL BROUSSE,INST CANCEROL & IMMUNOGENET,F-94800 VILLEJUIF,FRANCE
[2] CATHOLIC UNIV LOUVAIN,CLIN ST LUC,DEPT HEMATOL,B-1200 BRUSSELS,BELGIUM
来源：
ANTICANCER RESEARCH | 1981年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 9
页数：9
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH MALIGNANT-MELANOMA
    CAMACHO, FJ
    YOUNG, CW
    WITTES, RE
    CANCER TREATMENT REPORTS, 1980, 64 (01): : 179 - 181
  • [42] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH ACUTE-LEUKEMIA
    SKLAROFF, RB
    ARLIN, Z
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2063 - 2065
  • [43] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH MALIGNANT-LYMPHOMA
    SKLAROFF, RB
    STRAUS, D
    YOUNG, C
    CANCER TREATMENT REPORTS, 1979, 63 (05): : 793 - 794
  • [44] PHARMACOKINETICS OF 2 NEW 2-CHLOROETHYLNITROSOUREAS IN CANCER-PATIENTS SUBMITTED TO PHASE-II CLINICAL-TRIALS
    GODENECHE, D
    LABARRE, P
    CUSSAC, C
    MADELMONT, JC
    DUPUY, JM
    FONTANON, C
    TISSERANT, A
    CHOLLET, P
    BAUDRY, JP
    VEYRE, A
    DRUG INVESTIGATION, 1994, 7 (05): : 234 - 243
  • [45] PHASE-I AND PHASE-II STUDIES OF VINDESINE
    VALDIVIESO, M
    CANCER TREATMENT REVIEWS, 1980, 7 : 31 - 37
  • [46] PHASE-II EVALUATION OF VINDESINE IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    CARROLL, DS
    GRALLA, RJ
    KEMENY, NE
    CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 2097 - 2098
  • [47] PHASE-II TRIAL OF VINDESINE IN ADENOCARCINOMA OF THE LUNG
    SLEDGE, GW
    CLARK, GM
    VONHOFF, DD
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 557 - 558
  • [48] A PHASE-II TRIAL OF VINDESINE IN HEPATOCELLULAR CANCER
    FALKSON, G
    BURGER, W
    ONCOLOGY, 1995, 52 (01) : 86 - 87
  • [49] A BAYESIAN-APPROACH TO SAMPLE-SIZE DETERMINATION IN PHASE-II CANCER CLINICAL-TRIALS
    SYLVESTER, RJ
    CONTROLLED CLINICAL TRIALS, 1984, 5 (03): : 305 - 305
  • [50] SUMMARY OF RECOMMENDATIONS FOR COLONIC BIOMARKER STUDIES OF CANDIDATE CHEMOPREVENTIVE COMPOUNDS IN PHASE-II CLINICAL-TRIALS
    LIPKIN, M
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 94 - 98
12345